Limb Salvage Using Local Antibiotic Beads for Calcaneal Osteomyelitis With Multidrug-resistant Infection and Chronic Limb-threatening Ischemia Authors: Danah Alhunayan, Ahmed Alsaleh, Mahmood Makhdoomi, Salma Khuraibet, Ali Alnaser, Razzaq Alhunayan Published: 2026 ABSTRACT Summary:Calcaneal osteomyelitis in diabetic patients with chronic limb-threatening ischemia (CLTI) and multidrug-resistant (MDR) infection poses a significant reconstructive challenge. Limited perfusion, high plantar loading, and constrained antimicrobial delivery often narrow salvage options and increase the risk of major amputation. We report a case of recurrent calcaneal osteomyelitis in a 53-year-old man with type 2 diabetes, chronic kidney disease, peripheral vascular disease, CLTI, and polymicrobial MDR infection. Management included revascularization, serial debridement, culture-directed systemic therapy, negative-pressure wound therapy, hyperbaric oxygen therapy, structured offloading, and adjunctive local antibiotic delivery using calcium sulfate beads. Following recurrence, repeat calcaneal debridement and saucerization were performed, and vancomycin- and gentamicin-loaded calcium sulfate beads were placed individually into the calcaneal defect. The wound progressed with no recurrent infection or exposed bone. Complete epithelialization was achieved at 14 months, and the patient remained pain-free and independently ambulatory in offloading footwear. In recurrent calcaneal osteomyelitis complicated by CLTI and MDR infection, calcium sulfate antibiotic carriers may serve as a useful adjunct to staged multimodal limb salvage. By combining dead-space management with high local antibiotic delivery after repeat debridement, this approach may be considered in selected ischemic, infection-resistant presentations. Calcaneal osteomyelitis in patients with diabetes poses a significant reconstructive challenge due to limited soft-tissue coverage, high mechanical loading, and compromised vascular supply.1 When chronic limb-threatening ischemia (CLTI) and multidrug-resistant (MDR) organisms coexist, the risk of major amputation increases as impaired perfusion limits oxygen delivery, leukocyte activity, and antibiotic penetration.2,3 Although limb salvage in ischemic diabetic ulcers has been described, preservation of calcaneal integrity following recurrence after revascularization and systemic therapy is uncommon. Reports of targeted local antibiotic delivery in ischemic calcaneal osteomyelitis, particularly with MDR infection, remain limited.4,5 Local antimicrobial carriers achieve high intralesional concentrations independent of perfusion and provide a biologically rational adjunct when systemic delivery is limited.6,7 We present a case of recurrent calcaneal osteomyelitis with CLTI and MDR infection managed with staged multimodal salvage using adjunctive calcium sulfate antibiotic carriers. CASE PRESENTATION A 53-year-old man with type 2 diabetes (HbA1c 8.3%), ischemic heart disease, chronic kidney disease, and peripheral vascular disease presented with a draining left heel ulcer that evolved from a dry callus 2 months prior. Examination revealed a 3 × 3 cm lateral heel wound with necrosis, slough, purulence, and exposed calcaneus (Fig. 1). Bedside vascular examination demonstrated a palpable left popliteal pulse with audible distal Doppler signals. Although ankle-brachial index values were not available, arterial duplex demonstrated monophasic distal waveforms. Laboratory studies demonstrated leukocytosis (13 × 109/L) and elevated C-reactive protein (303 mg/L). Initial presentation showing a left heel ulcer with necrosis, slough, purulent drainage, and exposed calcaneus. Initial Salvage Angiography revealed severe stenosis of the tibioperoneal trunk and posterior tibial artery. Balloon angioplasty was performed, with completion angiography demonstrating improved posterior tibial flow and restoration of the pedal arch. He was then referred to the diabetic foot team for definitive wound management and infection control. Magnetic resonance imaging confirmed calcaneal osteomyelitis with intraosseous gas. Serial operative debridements drained purulence and excised necrotic tissue and devitalized bone. Initial procedures included partial ostectomy of the lateral calcaneus, with debridement carried out to viable bleeding tissue and bone margins (Fig. 2). Postdebridement view demonstrating excision of infected soft tissue and partial calcaneal resection to viable bleeding bone. Antimicrobial therapy was guided by infectious disease input and adjusted according to serial tissue and bone cultures, which initially demonstrated methicillin-sensitive Staphylococcus aureus with anaerobic organisms and later evolving polymicrobial growth. The patient completed approximately 7 weeks of culture-directed antimicrobial therapy. Negative-pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT) were continued throughout, with multidisciplinary glycemic, renal, and nutritional optimization. By week 7, the wound demonstrated more than 70% granulating tissue, improving inflammatory markers, and no clinical evidence of active infection. The patient was discharged with structured offloading and remained nonweight bearing for 6 weeks. His baseline insulin regimen was continued without major long-term changes, and he remained compliant with wound care and offloading. (See table, Supplemental Digital Content 1, which displays the timeline of key interventions, https://links.lww.com/PRSGO/F286.) Recurrence Seven weeks after discharge, the patient presented in the clinic with recurrent malodor, drainage, and purulence. Bone cultures grew polymicrobial MDR and extended-spectrum beta-lactamase (ESBL)-producing organisms, including ESBL Morganella morganii, ESBL Klebsiella pneumoniae, S. aureus, and Streptococcus constellatus. Infectious disease recommended readmission for intravenous antibiotics and source control. Magnetic resonance imaging demonstrated a new posteromedial calcaneal abscess with cortical destruction and intraosseous extension. Given recurrence despite revascularization, prior source control, and culture-directed antimicrobial therapy, below-knee amputation was considered. Definitive Salvage The patient wished to pursue limb salvage. Saucerization and curettage of the plantolateral calcaneus removed approximately 22%–30% of the calcaneus to bleeding viable margins. Calcium sulfate beads were prepared using 10-mL calcium sulfate mixed with 1-g vancomycin and 240-mg gentamicin. The 4.8-mm beads were placed individually into the inferolateral calcaneal cavity (Fig. 3), with placement confirmed radiographically. (See figure, Supplemental Digital Content 2, which displays the postoperative radiograph confirming bead placement, https://links.lww.com/PRSGO/F287.) Intraoperative placement of vancomycin- and gentamicin-loaded calcium sulfate beads into the inferolateral calcaneal defect. Partial wound closure was achieved with interrupted sutures to contain the beads within the defect. A nonadherent dressing interface was placed between the wound and NPWT foam. Continuous NPWT was applied 72 hours postoperatively, initially at −75 mm Hg to minimize bead displacement. Systemic antimicrobial therapy and HBOT continued. Postoperatively, the patient remained non–weight bearing for 12 weeks, then transitioned to partial weight bearing in a knee-high removable cast walker. The wound progressed to healthy granulation without exposed bone. Definitive soft-tissue coverage was discussed, but the patient declined further operative reconstruction. NPWT, offloading, and secondary-intention healing were pursued. At 12 months, the wound had contracted to <1 × 1 cm but remained incompletely epithelialized at the plantar heel margin. With total contact casting, complete epithelialization was achieved at 14 months, with durable coverage maintained at 18 months (Fig. 4). The patient remained pain-free and independently ambulatory in offloading footwear, with no further complications. Final 18-month follow-up after complete epithelialization, demonstrating durable soft-tissue coverage of the heel wound. DISCUSSION Calcaneal osteomyelitis in diabetic patients with CLTI and MDR organisms presents a complex reconstructive challenge.1,3 Minimal soft-tissue coverage, high mechanical loading, and limited vascular supply make the heel prone to recurrent breakdown. CLTI restricts oxygen-dependent host defenses and reduces antibiotic delivery, prompting bacterial persistence and biofilm survival despite repeated debridement.2,8 Effective management requires restoration of perfusion, infection control, and pressure offloading. In this case, recurrence despite revascularization, serial debridement, and systemic therapy likely reflected the combined burden of ischemic bone, resistant organisms, residual dead space, and plantar heel loading. Local antibiotic delivery was therefore used as an adjunct within this staged salvage framework. Calcium sulfate carriers were selected for their ability to fill irregular calcaneal defects, deliver high local antibiotic concentrations, resorb over time, and support dead-space management.6,7 Adjunctive measures optimized the wound environment. NPWT supported exudate control during bead resorption, whereas HBOT provided oxygenation support during later repair phases.9,10 Reports describing salvage of ischemic, MDR calcaneal osteomyelitis remain limited.4,5 This case illustrates how local antibiotic delivery, combined with NPWT, HBOT, and offloading, may be integrated into staged limb salvage when infection, impaired perfusion, and heel biomechanics narrow reconstructive options. The primary limitation of this report is that causality cannot be attributed to any single intervention. Revascularization, serial debridement, systemic antimicrobial therapy, local antibiotic delivery, NPWT, HBOT, and structured offloading were used concurrently. CONCLUSIONS In recurrent calcaneal osteomyelitis complicated by CLTI and MDR infection, calcium sulfate antibiotic carriers may provide a useful adjunct to staged multimodal limb salvage after repeat debridement. This multimodal approach supported durable limb preservation in this selected ischemic, infection-resistant presentation. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. ETHICAL APPROVAL This study reports a single-patient clinical case and does not constitute human subjects research. Informed consent was obtained from the patient for publication of this case and all accompanying images. Supplementary Material